Tenax Therapeutics (TENX) Receivables - Other (2011 - 2014)
Tenax Therapeutics' (TENX) quarterly Receivables - Other came in at $5424.0 in Q3 2014, down 77.2% year-on-year from $23789.0 in Q3 2013, and down 81.77% quarter-over-quarter from $29750.0 in Q2 2014.
Tenax Therapeutics (TENX) Receivables - Other (2011 - 2014) Analysis & Trends
Tenax Therapeutics has disclosed Receivables - Other across 4 years of filings, most recently posting $5424.0 for Q3 2014.
- Receivables - Other for Q3 2014 came in at $5424.0, down 77.2% year-over-year; the trailing twelve-month figure through Jul 2014 was $5424.0 (down 77.2% YoY), and the FY2014 annual result was $29750.0, down 69.08% from the prior year.
- Receivables - Other came in at $5424.0 for Q3 2014 at Tenax Therapeutics, down from $29750.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $375725.0 in Q4 2011 to a low of $5424.0 in Q3 2014.
- The 4-year median for Receivables - Other is $73121.5 (2013), against an average of $102026.9.
- Across the five-year window, Receivables - Other slumped 88.74% in 2012 and jumped 169.92% in 2013, its largest moves.
- Tenax Therapeutics' Receivables - Other stood at $375725.0 in 2011, then plunged by 88.74% to $42306.0 in 2012, then soared by 39.6% to $59058.0 in 2013, then plunged by 90.82% to $5424.0 in 2014.
- The last three Receivables - Other figures came in at $5424.0 (Q3 2014), $29750.0 (Q2 2014), and $113184.0 (Q1 2014), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Tenax Therapeutics | 120.33 Mn | 120.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2014 | 5,424.00 |
| Jul 31, 2014 | 5,424.00 |
| Apr 30, 2014 | 29,750.00 |
| Apr 30, 2014 | 29,750.00 |
| Jan 31, 2014 | 113,184.00 |
| Jan 31, 2014 | 113,184.00 |
| Oct 31, 2013 | 59,058.00 |
| Oct 31, 2013 | 59,058.00 |
| Jul 31, 2013 | 23,789.00 |
| Jul 31, 2013 | 23,789.00 |
| Apr 30, 2013 | 96,226.00 |
| Apr 30, 2013 | 96,226.00 |
| Jan 31, 2013 | 87,185.00 |
| Jan 31, 2013 | 87,185.00 |
| Oct 31, 2012 | 42,306.00 |
| Oct 31, 2012 | 42,306.00 |
| Jul 31, 2012 | 208,873.00 |
| Jul 31, 2012 | 208,873.00 |
| Apr 30, 2012 | 35,650.00 |
| Apr 30, 2012 | 35,650.00 |